ABERCROMBIE & FITCH CO /DE/
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Analysts updated recommendations for several companies. Baptista Research raised Abercrombie & Fitch's price target to $163.40 but downgraded it to hold. Eli Lilly was upgraded to buy by Berenberg, which also raised its target to $1,400. Other companies affected include Coinbase, Ulta Beauty, and Philip Morris.
Tilly's (TLYS) reported $163.5M revenue, up 8.1% YoY, beating estimates and raising guidance. Its stock rose 18.1%. Lululemon (LULU) reported $2.42B revenue, down 4.3% YoY, missing estimates and guidance, with its stock falling 18.7%. Gap (GAP) reported $3.65B revenue, down 2% YoY, missing estimates but raising full-year EPS guidance, with its stock up 3.5%. Abercrombie & Fitch (ANF) reported $1.27B revenue, up 4.8% YoY, beating estimates and raising guidance, with its stock up 34.8%.
Several retail stocks fell after August's Producer Price Index rose 5.4% YoY, driven by energy costs, and Brent crude oil surpassed $100/barrel, raising inflation concerns. Affected companies include Zumiez (ZUMZ, -4%), Macy's (M, -4.3%), Abercrombie & Fitch (ANF, -3.9%), and Victoria's Secret (VSXY, -4.2%). America's Car-Mart (CRMT, -4.8%) also declined, trading 96% below its 52-week high.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning ANF (ABERCROMBIE & FITCH CO /DE/). Coverage has been balanced: 1 bullish, 0 neutral, and 1 bearish.
Recent ANF coverage spans financial news, earnings and macro economy.
In the last 30 days, ANF insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($6.3M). The most active reporter was Lipesky Scott D., EVP and COO, with 2 filings.
Potential short-term downside as rating downgrade may pressure the stock.
Strong earnings beat and guidance raise fuel a sharp rally.
Apparel retailer sees price pressure from higher input costs.
The new analyst initiation and explicit $170 target can support near-term sentiment, but the article also flags the stock as ~28% over its stated intrinsic value.
Routine Form 4 insider sale with no 10b5-1 plan disclosed; may slightly affect near-term sentiment but is not a fundamental catalyst.
AlphAI scores every news story that mentions ANF with an AI model for sentiment and relevance, and aggregates insider trades from ABERCROMBIE & FITCH CO /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Analysts updated recommendations for several companies. Baptista Research raised Abercrombie & Fitch's price target to $163.40 but downgraded it to hold. Eli Lilly was upgraded to buy by Berenberg, which also raised its target to $1,400. Other companies affected include Coinbase, Ulta Beauty, and Philip Morris.
2 min readTilly's (TLYS) reported $163.5M revenue, up 8.1% YoY, beating estimates and raising guidance. Its stock rose 18.1%. Lululemon (LULU) reported $2.42B revenue, down 4.3% YoY, missing estimates and guidance, with its stock falling 18.7%. Gap (GAP) reported $3.65B revenue, down 2% YoY, missing estimates but raising full-year EPS guidance, with its stock up 3.5%. Abercrombie & Fitch (ANF) reported $1.27B revenue, up 4.8% YoY, beating estimates and raising guidance, with its stock up 34.8%.
3 min readSeveral retail stocks fell after August's Producer Price Index rose 5.4% YoY, driven by energy costs, and Brent crude oil surpassed $100/barrel, raising inflation concerns. Affected companies include Zumiez (ZUMZ, -4%), Macy's (M, -4.3%), Abercrombie & Fitch (ANF, -3.9%), and Victoria's Secret (VSXY, -4.2%). America's Car-Mart (CRMT, -4.8%) also declined, trading 96% below its 52-week high.
2 min readBMO Capital initiated coverage on Abercrombie & Fitch Co (ANF) with an 'Outperform' rating and a $170.00 price target. ANF is currently trading at $151.43, which is 28.2% overvalued compared to its GF Value™ of $118.08. The company has a GF Score™ of 88/100, indicating strong overall performance. Insider activity shows significant selling, with $10,301,752 in insider sell value over the last three months.
4 min readLipesky Scott D. (EVP and COO) sold 2,000 shares of ABERCROMBIE & FITCH CO /DE/ (ANF) at $146.82 ($0.29M total) on 2026-09-04.
2 min readBMO Capital Markets initiated coverage of the softlines sector with a cautious outlook, citing a weakening consumer and rising costs. The firm is bearish on athletic names, including Nike (target $30), Deckers ($70), Dick's Sporting Goods ($110), and lululemon ($70), all with earnings below consensus. BMO is more constructive on companies with self-help stories, rating Abercrombie & Fitch, Amer Sports, Carter's, and Steve Madden as Outperform.
2 min readAnalysts made several rating changes: TD Cowen initiated Faeth Therapeutics as buy, Barclays upgraded Sagimet Biosciences to overweight, JPMorgan upgraded Lithium Americas to overweight, and more. Price targets were also adjusted for companies like Affirm, Robinhood, and First Solar.
3 min readAbercrombie & Fitch Co. (NYSE:ANF) Director Kenneth B. Robinson sold 800 shares on Aug. 28, 2026, at $149.69 per share, totaling $119,752. He now holds 7,169 shares worth $1.06 million. The company has a market cap of $6.3 billion, TTM revenue of $5.3 billion, and a 335% total return since 2021.
4 min readAbercrombie & Fitch (ANF) shares rose 39% after reporting record Q2 sales of $1.27B, beating estimates. The company raised its FY2026 outlook, increased share buyback target to $500M, and forecast Q3 earnings of $2.90-$3.20 per share.
2 min readAbercrombie & Fitch Co (ANF) reported Q2 net sales of $2.38B, with Americas leading at $1.92B. The company's GF Score is 88/100, but its stock is 28.5% overvalued at $149.67. Strengths include strong brand portfolio and digital sales, while weaknesses include international challenges and insider selling. Growth opportunities lie in digital expansion and new markets, but threats include supply chain disruptions and macroeconomic conditions.
3 min read
